Literature DB >> 25882052

Response to letter regarding article, "Art of expertise in stroke telemedicine: imaging and the collaterome".

David S Liebeskind1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25882052      PMCID： PMC4442038          DOI： 10.1161/STROKEAHA.115.009327

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  5 in total

1.  Letter by Uchino et Al regarding article, "Art of expertise in stroke telemedicine: imaging and the collaterome".

Authors:  Ken Uchino; Peter A Rasmussen; Muhammad Shazam Hussain
Journal:  Stroke       Date:  2015-04-16       Impact factor: 7.914

2.  Art of expertise in stroke telemedicine: imaging and the collaterome.

Authors:  David S Liebeskind
Journal:  Stroke       Date:  2015-01-29       Impact factor: 7.914

3.  Improved prehospital triage of patients with stroke in a specialized stroke ambulance: results of the pre-hospital acute neurological therapy and optimization of medical care in stroke study.

Authors:  Matthias Wendt; Martin Ebinger; Alexander Kunz; Michal Rozanski; Carolin Waldschmidt; Joachim E Weber; Benjamin Winter; Peter M Koch; Erik Freitag; Jenrik Reich; Daniel Schremmer; Heinrich J Audebert
Journal:  Stroke       Date:  2015-01-29       Impact factor: 7.914

4.  Prehospital use of magnesium sulfate as neuroprotection in acute stroke.

Authors:  Jeffrey L Saver; Sidney Starkman; Marc Eckstein; Samuel J Stratton; Franklin D Pratt; Scott Hamilton; Robin Conwit; David S Liebeskind; Gene Sung; Ian Kramer; Gary Moreau; Robert Goldweber; Nerses Sanossian
Journal:  N Engl J Med       Date:  2015-02-05       Impact factor: 91.245

5.  Simultaneous ring voice-over-Internet phone system enables rapid physician elicitation of explicit informed consent in prehospital stroke treatment trials.

Authors:  Nerses Sanossian; Sidney Starkman; David S Liebeskind; Latisha K Ali; Lucas Restrepo; Scott Hamilton; Robin Conwit; Jeffrey L Saver
Journal:  Cerebrovasc Dis       Date:  2009-10-16       Impact factor: 2.762
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.